Clinical Trial Update: A Study to Assess the Relative Bioavailability of Three Formulations and Food Effect on GSK1322322 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update assessing the relative bioavailability of three formulations of GSK1322322 and the effect of food in healthy subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections

Drugs mentioned

• GSK1322322

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Bacterial | Phase 1 | Status: COMPLETED